NEUTRALIZING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY INHIBITS FURTHER GROWTH OF ESTABLISHED PROSTATE CANCER AND METASTASES IN A PRE-CLINICAL MODEL
- 1 March 1999
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 161 (3), 960-963
- https://doi.org/10.1016/s0022-5347(01)61829-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.JCI Insight, 1995
- Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancerHuman Pathology, 1995
- Characterization of the increase in vascular permeability induced by vascular permeability factor in vivoBritish Journal of Pharmacology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.JCI Insight, 1993
- Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of ProteinsEndocrine Reviews, 1992
- The Vascular Endothelial Growth Factor Proteins: Identification of Biologically Relevant Regions by Neutralizing Monoclonal AntibodiesGrowth Factors, 1992
- Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cellsMethods in enzymology, 1991
- Isolation of a human prostate carcinoma cell line (DU 145)International Journal of Cancer, 1978